Radiation Oncology

Dian Wang, MD, PhD Assistant Professor of Radiation Oncology Department of Radiation Oncology 8701 Watertown Plank Road Milwaukee, WI 53226 (414) 805-4496

Patient Care Emphases

• General Radiation Oncology
• Male Genital-Urinary Cancer
• Prostate Cancer
• Brachytherapy

Clinical Practice Locations

• Radiation Oncology Clinic at Froedtert & Medical College Clinics: (414) 805-4400
• Senator Joseph Andrea Cancer Center, Kenosha, at St. Catherine's Campus of United Healthcare Systems: (262) 577-8206
• Community Memorial Hospital: (262) 251-1000

Education

• PhD, Molecular Genetics of Cancer, Ohio State University, Columbus, OH (1996).
• Doctor of Medicine, Anhui College of Medicine, China (1984).

Training

• Board Certified American Board of Radiology (2002).
• Residency Radiation Oncology, Ohio State University, Columbus, OH (2002).

Representative Publications

• You L, Wang D, Galati AJ, Ross JA, Mass MJ, Amin S, Stoner JC, Stoner GD.  Tumor multiplicity, DNA adducts and k-ras mutation pattern of 5-methylchrysene in strain A/J mouse lung. Carcinogenesis,  15 (11): 2613-2618, 1994.
  
• Wang D, You L, Sneddon JM, Jamasbi R, Cheng S, Stoner GD.  Frame-shift mutation in codon 176 of the p53 gene in rat esophageal epithelial cells transformed by benzo (a) pyrene-dihydrodiol (BP-DHD).  Molecular Carcinogenesis, 14:84-93, 1995.
  
• Hong W, Wang D, Malarkey WB.  A PCR-derived, non-isotopic labeled prolactin cRNA probe suitable for in situ hybridization.  Endocrine Research, 21 (4), 793-802, 1995.
  
• Wang D, Weghorst CM, Calvert RJ, Stoner GD.  Mutations in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine.  Carcinogenesis, 17 (4):  625-630, 1996.
  
• Chen W, Weghorst CM, Sabourin CL, Wang Y, Wang D, Bostwick DG, Stoner, GD.  Absence of p16/MTS 1 alterations in human prostate cancer.  Carcinogenesis, 7 (12):  2603-2607, 1996.
  
• Wang D, Lang J, Weghorst CM, Sabourin CK, Stoner, GD.  Suppression of cell growth by wild-type P53 in tumor-derived rat esophageal epithelial cells.  Journal of International Oncology, 1201-1206, 1996.
  
• Wang D, Song H, Evans JA, Lang JC, Schuller DE, Weghorst CM.  Mutations and down regulation of the transforming growth factor type II receptor gene in primary squamous cell carcinomas of the head and neck.  Carcinogenesis 81 (11):  2285-2290, 1997.
  
• Lynch MA, Nakashima R, Song H, DeGroff V, Wang D, Enomoto T, Weghorst CM.  Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma, Cancer Research, 58 (19):  4227-4232, 1998.
  
• Nag S, Wang D, Wu H, Bauer CJ, Chambers RB, Davidorf FH.  Custom-made "Nag" plaques for 125I brachytherapy, Int. J Radiation Oncology Biol Phys, 56 (5): 1373-1380, 2003.
  
• Li XA, Wang JZ, Jursinic PA, Lawton CA, Wang D.  Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer. Int J Radiation Oncology Biol Phys, 2005 (in press).
  
• Feng Y, Chen S, Stoner GD, Wang D.  Black raspberry extracts induce growth inhibition in human oral carcinoma cells. IJCP, 2005 (in press).
  
• Wang D, Grecula JC, Gahbauer RA, Schuller DE, Lang JC.  P16 gene alterations and clinical correlation with treatment outcome in locally advanced squamous cell carcinoma of the head and neck, 2005.
  
• Li XA., Wang JZ, DiBiase SJ, Wang D. Radiobiological considerations in designing equivalent treatment regimens for prostate radiotherapy. Considered for publication in Medical Phys.
  
• Wang D, Chen S, Feng Y, Campbell HB, Tang X, Campbell WB.  Reduced expression of 15-lipoxygenase 2 in human head and neck Carcinoma. Considered for publication in Molecular Carcinogenesis.
  
• Wang D, Schultz CJ, Jursinic PA, Bialkowski M,  Zhu R, Brown WD, Rand SD, Campbell BH, Wong S, Li XA.  Initial experience of FDG-PET/CT guided IMRT study for head and neck carcinoma. Submitted to Int J Radiat Oncol Biol Phys.